Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone-naloxone versus methadone in methadone-maintained opioid-dependent adults
ACTRN12608000024347Phase 3Completed
- Sponsor
- The Langton Centre
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methadone and naloxone in opioid use disorder (OUD) (3 arms), sponsored by The Langton Centre. Primary endpoint: Severity of opioid withdrawal symptoms. Started Feb 2007; status: completed.
02
Drugs
methadonenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ACTRN12608000024347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000024347.